ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $136,000 | +22.5% | 33,238 | +6.6% | 0.00% | – |
| Q4 2021 | $111,000 | +19.4% | 31,184 | +22.0% | 0.00% | -100.0% |
| Q3 2021 | $93,000 | +3.3% | 25,560 | +23.3% | 0.00% | – |
| Q2 2021 | $90,000 | +25.0% | 20,735 | +17.6% | 0.00% | – |
| Q1 2021 | $72,000 | +26.3% | 17,634 | +22.6% | 0.00% | – |
| Q4 2020 | $57,000 | +90.0% | 14,386 | -18.4% | 0.00% | – |
| Q3 2015 | $30,000 | +172.7% | 17,634 | +225.8% | 0.00% | – |
| Q2 2015 | $11,000 | +10.0% | 5,413 | +50.7% | 0.00% | – |
| Q1 2015 | $10,000 | +11.1% | 3,592 | +1.0% | 0.00% | – |
| Q4 2014 | $9,000 | +28.6% | 3,557 | -8.0% | 0.00% | – |
| Q3 2014 | $7,000 | -36.4% | 3,866 | -9.5% | 0.00% | – |
| Q2 2014 | $11,000 | -21.4% | 4,273 | +4.9% | 0.00% | – |
| Q1 2014 | $14,000 | -22.2% | 4,075 | +1.0% | 0.00% | – |
| Q4 2013 | $18,000 | -67.9% | 4,034 | -70.5% | 0.00% | – |
| Q3 2013 | $56,000 | +86.7% | 13,694 | +89.0% | 0.00% | – |
| Q2 2013 | $30,000 | – | 7,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |